Latest Conference Articles

ASCO/ONS Chemotherapy Safety Standards Updated to Include All Delivery Settings

The chemotherapy safety standards developed by ASCO and ONS were recently updated to reflect the fact that chemotherapy is delivered in a variety of settings.

Krista Rubin on Managing Ipilimumab-related Dermatitis

Krista Rubin, MS, RN, FNP-BC, from Massachusetts General Hospital Cancer Center, on Managing Ipilimumab-related Dermatitis.

Identifying Appropriate Patients for HER2-Targeted Therapies

Standards for identifying appropriate populations for treatment with HER2-targeted therapies are evolving.

Michael Eckenfels on Bortezomib Delivery Route Changes

Michael Eckenfels, RN, OCN, from MD Anderson Cancer Center, on Changes to the Bortezomib Delivery Route.

Anna Vioral on Multidisciplinary Chemotherapy Safety Standards

Anna Vioral, RN, OCN, from West Penn Allegheny Health System, on Multidisciplinary Chemotherapy Safety Standards.

Treating Patients Enrolled in Clinical Trials

All oncology nurses-not just nurse researchers-will need to understand the fundamentals of clinical trials as patient access to the studies continues to expand.

Oncology Nurses Can Help Mitigate Treatment-Related Side Effects in Head and Neck Cancers

Treatment of head and neck cancer often leaves patients with aftereffects that are bothersome at the very least and life-altering at their worst.

Anne Katz Discusses Cancer and Sexuality

Anne Katz, from the University of Manitoba, Discusses Cancer and Sexuality

Talking to Prostate Cancer Patients About Sipuleucel-T: Nurses Assure Smooth Sailing During Treatment

Nurses play vital roles in assuring that patients with metastatic castration-resistant prostate cancer (mCRPC) are optimally treated with sipuleucel-T.

Oncology Nurses Need to Enhance Their Genetics and Genomics Competency

A pilot study has demonstrated a lag in the integration of genetics and genomics into nursing practice, which is an increasingly required professional skill for oncology nurses.

Jayshree Shah on the Safety and Efficacy of Nilotinib

Jayshree Shah, from John Theurer Cancer Center, on the Safety and Efficacy of Nilotinib for Patients With CML

Kim Kelly on Clinical Practice Guidelines for Mucositis

Kim Kelly, from John Theurer Cancer Center, on the Updated MASCC/ISOO Clinical Practice Guidelines for Mucositis

Oncology Nursing Expert Previews 37th Annual ONS Congress

With four full days of programming, dozens of exhibitors, satellite symposia, and thousands of members in attendance, trying to fit everything in at the ONS Annual Congress can prove quite challenging.

Oncology Nursing Society Elects New President

This year's ONS Annual Congress marks the first at which Mary Gullatte, PhD, RN, APRN, BC, AOCN, will serve as the organization's president.

Conference Coverage From the ATA Annual Meeting

Conferencd coverage from the 82nd Annual Meeting of the American Thyroid Association (ATA).

Conference Coverage From AACE Coming Soon

Stay tuned for live coverage from the American Association of Clinical Endocrinologists (AACE) 21st Annual Scientific and Clinical Congress.

Preview: 2012 ASCO Annual Meeting Coverage

OncLive.com will be on-site at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.

Dr. Tripathy Discusses Breast Cancer Prevention

Dr. Debu Tripathy, from the USC Norris Comprehensive Cancer Center, Discusses Breast Cancer Prevention

Emerging Therapies for HER2-Positive and Triple-Negative Breast Cancers

Recognition of breast cancer subtypes and research into their underlying biologies is driving the development of new therapies.

Dr. Gralow on Breast Cancer Adjuvant Bisphosphonates

Dr. Julie Gralow, from the Seattle Cancer Care Alliance, on Adjuvant Bisphosphonates for Breast Cancer

Immunotherapy Emerges as Promising Strategy in Breast Cancer

Next-generation immunotherapy in breast cancer treatment is an active field of scientific exploration with the potential to yield a vaccine.

Dr. Osman on the 29th Miami Breast Cancer Conference

Dr. Daniel Osman, the program chair for the Miami Breast Cancer Conference, Discusses the 29th Annual Meeting

Advances in Genomics Mask Complexities

Technological advances in genomics have prompted a "sea change" in breast cancer drug development and treatment.

Patients, Surgeons Face Hurdles in Making Breast Cancer Decisions

The choice of breast-conserving surgery over mastectomy is often based on fear of recurrence and death rather than clinical evidence.

29th Annual Miami Breast Cancer Conference Slideshow

Pictures from the Annual Miami Breast Cancer Conference, at the Fontainebleau Miami Beach hotel, in Florida.

Four Key Areas Are Focus of ASCO/SABCS Highlights

Debu Tripathy, MD, culled the highlights from abstracts presented in 2011 at the ASCO annual meeting in Chicago, Illinois, and at the CCTR-AARC SABCS in Texas.

29th Annual Miami Breast Cancer Conference Opens

The impact of molecular and genomic advancements on the treatment of patients with breast cancer will be among the prime topics of discussion.

Miami Breast Cancer Conference Founder Keeps Focus on Future

As the Miami Breast Cancer Conference enters its 29th year, Osman continues to organize the gathering and pack the 4-day meeting with faculty speakers.

Dr. Steensma Discusses Iron Chelation Therapy for MDS

Dr. David Steensma, from Dana-Farber Cancer Institute, Discusses Iron Chelation Therapy for MDS

Managing Chronic Myeloid Leukemia Treatment

Certain characteristics of patients with CML can affect therapeutic outcomes.